NASDAQ:NVCR
NovoCure Limited Stock News
$16.47
+0.340 (+2.11%)
At Close: May 10, 2024
3 Biotech Stocks to Buy in April
10:10am, Sunday, 03'rd Apr 2022 The Motley Fool
They're good picks for very different reasons.
3 Biotech Stocks to Buy in April
06:10am, Sunday, 03'rd Apr 2022
They're good picks for very different reasons.
Novocure to Report First Quarter 2022 Financial Results
07:30am, Friday, 01'st Apr 2022
ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced today that it will report financial results for the first quarter 2022 on Thursday, April 28, 2022, before the U.S. financial mar
This Incredibly Promising Stock Will Trade Like a Volatile Biotech
11:00am, Friday, 25'th Mar 2022 The Motley Fool
This medical device company has major potential.
This Incredibly Promising Stock Will Trade Like a Volatile Biotech
07:00am, Friday, 25'th Mar 2022
This medical device company has major potential.
5 Growth Stocks That Can Turn $250,000 Into $1 Million by 2030
10:04am, Sunday, 13'th Mar 2022 The Motley Fool
There's a realistic path for each of these stocks to deliver gains of 4x or more this decade.
Is NovoCure Limited (NASDAQ: NVCR) Still A Loss Stock Despite Being Down -11.99% YTD?
02:00pm, Saturday, 12'th Mar 2022 Marketing Sentinel
During the last session, NovoCure Limited (NASDAQ:NVCR)’s traded shares were 0.59 million, with the beta value of the company hitting 0.87. At the end of the trading day, the stock’s price was $66.08, reflecting an intraday loss of -5.46% or -$3.82. The 52-week high for the NVCR share is $232.76, that puts it down -252.24 … Is NovoCure Limited (NASDAQ: NVCR) Still A Loss Stock Despite Being Down -11.99% YTD? Read More »
3 Biotech Stocks That Can Make You Richer in March (and Beyond)
12:04pm, Sunday, 06'th Mar 2022 The Motley Fool
These biotechs have promising near-term and long-term prospects.
3 Biotech Stocks That Can Make You Richer in March (and Beyond)
07:04am, Sunday, 06'th Mar 2022
These biotechs have promising near-term and long-term prospects.
NovoCure: Overview Of The GBM Business
02:56pm, Monday, 28'th Feb 2022
NovoCure's revenue growth has slowed down in recent quarters.
Top 3 Cheap Healthcare Stocks You Shouldn't Ignore.
11:35am, Saturday, 26'th Feb 2022
Some popular names in the healthcare sector have been down even by about 50% from their highs recently. But there are lots of opportunities in this sector.
Novocure (NVCR) Q4 2021 Earnings Call Transcript
07:00pm, Thursday, 24'th Feb 2022 The Motley Fool
NVCR earnings call for the period ending December 31, 2021.
Novocure (NVCR) Q4 2021 Earnings Call Transcript
07:00pm, Thursday, 24'th Feb 2022 The Motley Fool
NVCR earnings call for the period ending December 31, 2021.
